Danielle E. Berbrier

Danielle E. Berbrier

Auto-generated profile, based on publicly available information

Danielle E. Berbrier

McGill University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Journal of Applied Physiology
Verified
Journal Article
Closed access
DBDanielle E. Berbrier
Danielle E. Berbrier
CLCheryl A. Leone
Cheryl A. Leone
TATessa E. Adler
Tessa E. Adler
JBJeffrey R. Bender
Jeffrey R. Bender
HTHugh S. Taylor
Hugh S. Taylor
CUCharlotte W. Usselman
Charlotte W. Usselman
We present evidence for marked endothelial dysfunction in lean women with androgen excess polycystic ovary syndrome (AE-PCOS) that is 1) associated with free testosterone levels, 2) impaired relative to overweight/obese women with AE-PCOS, and 3) unchanged following short-term ethinyl estradiol supplementation. These data indicate an important direct effect of androgens on the vascular system in women with AE-PCOS. Our data also suggest that the relationship between androgens and vascular health differs between phenotypes of AE-PCOS.

29 August 2023 in Experimental Physiology
Verified
Journal Article
Open access
ADAlicia Duval
Alicia Duval
WHWill Huckins
Will Huckins
DBDanielle E. Berbrier
Danielle E. Berbrier
CUCharlotte W. Usselman
Charlotte W. Usselman
Polycystic ovary syndrome (PCOS) is a complex disorder characterized by reproductive abnormalities, cardiometabolic disturbances and a heightened risk of cardiovascular disease. A small but compelling body of research demonstrates that females with PCOS present with elevated muscle sympathetic nerve activity (MSNA) at rest. Heightened MSNA is present in lean, overweight and obese females with PCOS, but limited evidence suggests that androgens may be more strongly linked to elevated MSNA in lean females with PCOS than in obese females with PCOS. Although the specific mechanisms underlying elevated MSNA in PCOS remain elusive, sympathetic activation is implicated in the progression of several cardiovascular diseases and may contribute to the cardiovascular pathophysiology of PCOS. Encouragingly, MSNA appears responsive to non‐pharmacological intervention, making the sympathetic nervous system a promising therapeutic target to mitigate cardiovascular risk in PCOS. This brief review summarizes the existing evidence regarding elevated MSNA, cardiovascular risk profile and vascular function, as well as the potential for clinical intervention and future research directions in females with PCOS.

15 March 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
DCDomenica Cirone
Domenica Cirone
DBDanielle E. Berbrier
Danielle E. Berbrier
JGJenna C Gibbs
Jenna C Gibbs
CUCharlotte W. Usselman
Charlotte W. Usselman

5 May 2025 in The Journal of Physiology
Verified
Journal Article
Open access
ZAZoe H. Adams
Zoe H. Adams
DBDanielle E. Berbrier
Danielle E. Berbrier
BSBrittany K. Schwende
Brittany K. Schwende
WHWill Huckins
Will Huckins
CRCory T. Richards
Cory T. Richards
RLRachel N Lord
Rachel N Lord
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in premenopausal females. The condition is associated with an increased prevalence of cardiovascular risk factors, including hypertension. Observational studies report that some blood pressure control mechanisms are altered in PCOS compared to controls (sympathetic nervous system activity, endothelial and vasodilator function, renin angiotensin aldosterone system activation), and that these impairments correlate with androgen hormone levels, which are chronically elevated in the condition. As such, hyperandrogenism is the proposed locus of origin for the link between PCOS and cardiovascular dysfunction, yet the underlying mechanisms remain poorly understood. Preclinical work has provided some insight into how androgens modulate blood pressure control in PCOS. However there are marked discrepancies between the effects of androgens in cellular and tissue studies versus in vivo animal and human PCOS studies. This may be related to the heterogeneity of the preclinical models and samples used in this research and whether preclinical work is modelling hyperandrogenism in physiologically relevant terms for PCOS. This review collates preclinical and clinical evidence to summarise what is known and what remains unknown about cardiovascular control mechanisms in PCOS. We examine aspects of blood pressure regulation that are altered in other hypertensive cohorts, presenting current evidence for a mechanistic role of androgens on these systems, while acknowledging the diverse experimental models and participant cohorts from which the results are derived. image

1 February 2025 in Journal of Applied Physiology
Verified
Journal Article
Open access
DBDanielle E. Berbrier
Danielle E. Berbrier
YCYasmine Coovadia
Yasmine Coovadia
DMDivine Malenda
Divine Malenda
CUCharlotte W. Usselman
Charlotte W. Usselman
Young, lean, and otherwise healthy females with polycystic ovary syndrome (PCOS) demonstrated exaggerated blood pressure responses to the cold pressor test (CPT) relative to controls. CPT responses were associated with bioavailable androgens, suggesting that hyperandrogenism contributes to exaggerated responses to the CPT in PCOS. Given associations between CPT responsiveness and the subsequent development of hypertension, these findings add to mounting evidence for increased cardiovascular risk even in lean females with PCOS.

1 August 2025 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
WHWill Huckins
Will Huckins
SDShannon I. Delage
Shannon I. Delage
DBDanielle E. Berbrier
Danielle E. Berbrier
DSDerek A. Skolnik
Derek A. Skolnik
HKHana Sandra Aiko Keightley
Hana Sandra Aiko Keightley
CUCharlotte W. Usselman
Charlotte W. Usselman
We studied a young and lean cohort of females with PCOS to determine whether acute hyperemic responses to exercise would be adversely impacted by PCOS, even in a relatively healthy cohort. Despite similar blood pressure responses to exercise, acute hyperemic responses to single-leg exercise to exhaustion were smaller in PCOS than controls. This provides novel information in an attempt to understand the cardiovascular dysfunction characteristic of females with PCOS.